Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Propranolol and depression

W M Petrie, R J Maffucci, R L Woosley

    The American Journal of Psychiatry
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Propranolol can cause severe depression in some patients. Discontinuing the medication often resolves these depressive episodes, highlighting the need for physician awareness.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A computerized scoring system to improve assessment of heparin-induced thrombocytopenia risk.

    Journal of thrombosis and haemostasis : JTH·2018
    Same author

    Medical decision support systems and therapeutics: The role of autopilots.

    Clinical pharmacology and therapeutics·2015
    Same author

    It is important research, but why is it necessary?

    Clinical pharmacology and therapeutics·2013
    Same author

    Is it possible for FDA regulatory scientists and industry scientists to work together?

    Clinical pharmacology and therapeutics·2012
    Same author

    The Critical Path Institute's approach to precompetitive sharing and advancing regulatory science.

    Clinical pharmacology and therapeutics·2010
    Same author

    The Coalition Against Major Diseases: developing tools for an integrated drug development process for Alzheimer's and Parkinson's diseases.

    Clinical pharmacology and therapeutics·2009
    Same journal

    Global Prevalence of Obsessive-Compulsive and Related Disorders: A Systematic Review and Modeling Study.

    The American journal of psychiatry·2026
    Same journal

    Treatment Patterns and Barriers to Care Among U.S. Adults With Co-Occurring Substance Use Disorder and Mental Illness.

    The American journal of psychiatry·2026
    Same journal

    Implantable Neuromodulation Devices in Psychiatry: Human Fidelity and Implementation Challenges.

    The American journal of psychiatry·2026
    Same journal

    Convergent Network Localization of Brain Stimulation Targets for Trait Anxiety.

    The American journal of psychiatry·2026
    Same journal

    2026 Annual Meeting: President-Elect Address.

    The American journal of psychiatry·2026
    Same journal

    2026 Annual Meeting: CEO and Medical Director's Address.

    The American journal of psychiatry·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Psychiatry
    • Cardiology

    Background:

    • Propranolol is a beta-blocker widely used for various medical conditions.
    • Depression is a significant adverse effect that can impact patient compliance and quality of life.

    Observation:

    • Three patients experienced severe depressive episodes following propranolol administration.
    • These episodes were linked to propranolol dosage and resolved upon cessation of the drug.

    Findings:

    • A dose-dependent relationship was observed between propranolol use and the onset of depressive episodes.
    • The prompt remission of depression upon propranolol discontinuation suggests a direct causal link.

    Implications:

    • Physicians should be vigilant for potential propranolol-induced depression, particularly in patients with pre-existing depressive disorders.
  • Early recognition and management can mitigate this adverse drug reaction and improve patient outcomes.